Baset Pharmaceuticals Ltd is pioneering a new era in oncology and autoimmune diseases, dedicated to developing groundbreaking antibody therapies with superior efficacy and safety for patients.
Our long-term vision is to transform cancer treatment by delivering highly specific and potent therapeutic agents, expanding effective options for patients worldwide.
Registered in England and Wales, Baset Pharmaceuticals Ltd is committed to advancing therapeutics through rigorous scientific innovation and a patient-centric approach. We are actively seeking strategic partners to help bring these life-changing therapies to patients in need.
Feb 2025
Focusing on conditional activation to overcome current treatment limitations.
August 2025
We are optimizing multispecific antibody constructs for enhanced efficacy and safety.
Pinpointing cancer cells with accuracy.
New ways to attack tumors.
Minimizing side effects for patients.
Phone: +49 1623977520
Email: ahmed.somaida@basetpharma.com
Address: 73-75 Aldgate High Street, London, England, EC3N 1BD
Working Hours: Monday - Friday: 9 AM - 5 PM